The post Silicon Valley Bank appeared first on MedTech Investing Conference 2013.

Serving you in how to

• Finding the optimal pathway for the CE mark approval
• Document your products at the Medtech Testfacility at Oslo University Hospital
• Establishing a virtual office at the Medtech Growth House, Oslo
• Market intelligence for the European market

Oslo medtech is a National Cluster supporting and nourishing the business development of superior medical research, stimulating the development of a competitive Norwegian Medtech and eHealth industry – now counting 150 members.

www.oslomedtech.no

The post Oslo Medtech appeared first on MedTech Investing Conference 2013.

IBF Conference attendees are eligible for preferential rates on subscriptions.

For more information, contact Greg Winterton at (+1) 646 223 6787 or
email greg.winterton@thomsonreuters.com

The post VCJ appeared first on MedTech Investing Conference 2013.

For more information, please visit http://www.ge.com/company/ge-ventures.

The post GE Ventures appeared first on MedTech Investing Conference 2013.

CEOs, their investors and board members, seek Julie as a valuable advisor as their businesses grow. She has over a decade of success placing executive management across every functional area from early-stage through exit.

Julie founded AES in 2003 after garnering awards for the medical device recruiting practice she established in Chicago. Early in her career, she was a Director at Foote, Cone & Belding, a global advertising firm. She also held leadership positions in marketing and operations at Walt Disney World and Disneyland Paris.

Julie enjoys the blessings of a full life with her husband, and business partner, Rich, and their four young children.

The post Julie Allen appeared first on MedTech Investing Conference 2013.

Prior to Sorin, Mr. Andrle co-founded, developed, and sold three medical device companies in the Minneapolis area. Teramed was focused on an endovascular system to treat abdominal aortic aneurysms and was acquired by Johnson&Johnson.  Myocor developed an implantable device to treat mitral valve regurgitation and was acquired by Edwards. And StarFire Medical developed technology to treat brain aneurysms and was acquired by NFocus Neuromedical.

Mr. Andrle also spent five years as a Vice President of Boston Scientific.  Mr. Andrle lead a new business unit that developed a number of peripheral vascular catheters and guidewires that eventually accounted for over $100 million in sales for Boston Scientific.  He also worked for Institutional Venture Partners in medical device investments and spent five years at Baxter International working in marketing in the renal therapy business.  He has an MBA from the Stanford Graduate School of Business and a BS in Chemical engineering from the University of Notre Dame.

The post Edward S. Andrle appeared first on MedTech Investing Conference 2013.

For over a decade, AES has worked closely with CEOs to build the leadership teams and company cultures of more than 25 early-stage companies. CEOs, their investors and board members, seek AES as valuable advisors as their businesses grow. From development through exit, we work across all functional areas and levels, helping our client companies succeed.

AES has earned a reputation of excellence, having achieved and sustained ratios four times better than industry average. We create quantifiable value for companies by our refined, proven approach.

Our consultative and company-based approach is designed with the CEO in mind. Whether it’s one critical hire or 25, our focused approach saves time, builds the right team – throughout every evolving stage of development — generates a better return, and becomes the catalyst for growth and successful exits.

The post Allen Executive Search, Ltd. appeared first on MedTech Investing Conference 2013.

The post Baker Tilly Virchow Krause, LLP appeared first on MedTech Investing Conference 2013.

The post Dennis Wahr MD appeared first on MedTech Investing Conference 2013.

Recently, at the beginning of this year, after almost-11 years as a Venture Capitalist, and 10 years prior in operating companies, Kevin launched MentorCatalyst, to pursue his passion for company-building and for working more intimately with entrepreneurs. At MentorCatalyst, Kevin is reinventing the craftsman-styled approach to working with startup MedTech teams, deeply engaging and focusing on a select few startup medical device companies in a committed manner, over the long-term, providing comprehensive leadership, experience and counsel.

Kevin currently serves, or has served, in board or advisory roles with companies which include: Acclarent (acquired: Johnson & Johnson), Autonomic Technologies, Cereve, LipoSonix (acquired: Medicis), Lutonix(acquired: Bard), Microfabrica, Respicardia, NeoGuide Systems (acquired: IntuitiveSurgical), Rox Medical, Second Sight Medical, St. Francis Medical (acquired: Kyphon) and The Innovation Factory.

Prior to founding MentorCatalyst, Kevin was a Managing Director at Versant Ventures from 2002-2013, where he focused on investing in and building early stage medical device companies. Kevin also has deep operating experience prior to Venture Capital, having held a variety of leadership roles in marketing and business development at Guidant Corporation, business development at Heartstream, and Engineering Development and Management at Hughes Aircraft Company.

Kevin holds both Bachelor’s and Master’s degrees in Mechanical Engineering, specializing in product design, as well as an MBA, all from Stanford University.

The post Kevin Wasserstein appeared first on MedTech Investing Conference 2013.